Participants will be randomly assigned to either the time restricted feeding group with a daily eating period of 8 hours or the control group with a daily eating period of greater than or equal to 12 hours. There are 2 in-person study visits to have blood, urine and vital signs collected and 8 remote or phone visits with a psychologist or dietician to assist with the eating schedule. The study will take last 3 1/2 months.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Advanced Glycation End Products (AGE) as Assessed by Plasma
Timeframe: Visit 1 (0 weeks), Visit 2 (14 weeks)
Change in sRAGE(Soluble Receptor for AGE) Levels
Timeframe: Visit 1 (0 weeks), Visit 2 (14 weeks)
Assess Feasibility and Adherence to Time Period of Eating Recommendations in Both Study Groups.
Timeframe: Visit 1 (0 weeks), Visit 2 (14 weeks)